Concordant CpG island methylation in hyperplastic polyposis

American Journal of Pathology

Volumn 160, Issue 2, 2002, Pages 529-536

  Chan, Annie On On ^a   Issa, Jean Pierre J ^a   Morris, Jeffrey S ^a   Hamilton, Stanley R ^a   Rashid, Asif ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLATOR PHENOTYPE; ADENOCARCINOMA; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COLON CARCINOGENESIS; COLON POLYPOSIS; COLORECTAL CANCER; CPG ISLAND; FEMALE; GENE MUTATION; GENETIC PREDISPOSITION; HUMAN; HYPERPLASIA; MALE; METHYLATION; ONCOGENE K RAS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TRANSACTIVATION; X CHROMOSOME INACTIVATION;

EID: 0036169109     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)64872-9     Document Type: Article

References (43)

1. Lessons from hereditary colorectal cancer
2. Gene defects in colorectal tumorigenesis
3. Cancer genetics: Tumor suppressor meets oncogene
4. Microsatellite instability: The mutator that mutates the other mutator
5. The genetic basis of colorectal cancer: Insights into critical pathways of tumorigenesis
6. CpG-rich islands and the function of DNA methylation
7. Chromosome imprinting and inactivation in the early mammalian embryo
8. Methylation of the estrogen receptor CpG island links ageing and neoplasia in human colon
9. Alterations in DNA methylation: A fundamental aspect of neoplasia
10. Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers
11. Association between CpG island methylation and microsatellite instability in colorectal cancer
12. Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer
13. 6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia
14. Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines
15. CpG island methylator phenotype in colorectal cancer
16. Distinct genetic profiles in colorectal tumors with or without the CpG island methylator phenotype
17. CpG island methylation in colorectal adenomas
18. The primary function of a redundant Sp1 binding site in the mouse aprt gene promoter is to block epigenetic gene inactivation
19. Epigenetic silencing of RNA polymerase I transcription: A role for DNA methylation and histone modification in nucleolar dominance
20. Sp1 sites in the mouse aprt gene promoter are required to prevent methylation of the CpG island
21. Nature and significance of hyperplastic polyps of the human colon
22. Hyperplastic polyps of the large bowel
23. Metaplastic (hyperplastic) polyps of the large bowel: Benign neoplasms after all?
24. A case of metaplastic polyposis of the colon associated with focal adenomatous change and metachronous adenocarcinomas
25. Polyposis coli: The clinical spectrum in adults
26. Multiple metaplastic (hyperplastic) polyposis of the colon
27. Dysplastic and malignant areas in hyperplastic polyps of the large intestine
28. Phenotypic and molecular characteristics of hyperplastic polyposis
29. Mixed epithelial polyps in association with hereditary non-polyposis colorectal cancer providing an alternative pathway of cancer histogenesis
30. DNA microsatellite instability in hyperplastic polyps, serrated adenomas, and mixed polyps: A mild mutator pathway for colorectal cancer?
31. Neoplastic progression occurs through mutator pathways in hyperplastic polyposis of the colorectum
32. Methylation-specific PCR: A novel PCR assay for methylation status of CpG islands
33. Longitudinal data analysis for discrete and continuous outcomes
34. Methylation of the estrogen receptor CpG island in lung tumors is related to the specific type of carcinogen exposure
35. Molecular determinants of dysplasia in colorectal lesions
36. High frequency of K-ras mutations in human colorectal hyperplastic polyps
37. Phenotypic and genotypic characteristics of aberrant crypt foci in human colorectal mucosa
38. Cytogenetic aberrations in colorectal adenocarcinomas and their correlation with clinicopathologic features
39. Genomic instability in colorectal cancer: Relationship to clinico pathological variables and family history
40. Association of K-ras mutations with p16 methylation in human colon cancer
41. Methylation of O-6-methyrguanine DNA methyltransferase characterizes a subset of colorectal cancer with low-level DNA microsatellite instability
42. 6-methylguanine-DNA methyltransferase is associated with G:C to A:T transition mutations in p53 in primary colorectal tumorigenesis
43. HPP1: A transmembrane protein encoding gene commonly methylated in colorectal polyps and cancers